News Posts List
Genentech Provides Update on Avastin Program
05/15/2008
Genentech, Inc. DNA today provided an overview of several clinical studies of Avastin(R) in multiple types of cancer that will be presented during the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place May 30 to June 3 in Chicago.
ZymoGenetics Announces Publication of Five IL-21 ASCO Abstracts
05/15/2008
Renal cell cancer is the lead indication for IL-21, and previously, ZymoGenetics presented interim results from a Phase 1 trial combining IL-21 with Nexavar(R) (sorafenib) tablets.
Active Biotech to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
05/15/2008
ANYARA - a novel cancer targeted therapy - is in Phase III trials with 500 advanced renal cell cancer patients.
Update understanding of kidney cancer prevention
05/14/2008
Nephrectomy before immunotherapy in patients with metastatic renal cell cancer (RCC) will improve patient outcome.
Scientists discover compound that prevents cancer in lab
05/14/2008
Scientists are studying many diseases and conditions for treatment with Flex-Hets, like polycystic kidney disease, kidney cancer and ovarian cancer.
Active Biotech advances ANYARA into Phase III clinical trial
05/13/2008
An interim analysis has been performed in Active Biotech AB's (OMX Nordic: ACTI) ongoing Phase II/III clinical study of ANYARA, in patients with advanced renal cell cancer.
Woman helps win cancer drugs
05/12/2008
Kidney Cancer Association member and UK activist, Kate Spall, helps cancer patients to get life-extending drugs after her mother lost a battle for treatment.
How the NHS is letting my father die
05/10/2008
I never for a moment thought that a life could be decided by something as arbitrary as one's address.
Potato chips up kidney cancer risk
05/10/2008
Dutch scientists believe that acrylamide, a component found in French fries, potato chips, bread and coffee, can cause kidney cancer.
Appeal launched by parents of Jessica Harrison
05/09/2008
The parents of inspirational Jessica, whose story touched the hearts of Teessiders today launched a fundraising appeal in her memory.